DELLO RUSSO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 17.663
AS - Asia 6.485
EU - Europa 5.412
SA - Sud America 1.357
Continente sconosciuto - Info sul continente non disponibili 769
AF - Africa 424
OC - Oceania 18
AN - Antartide 1
Totale 32.129
Nazione #
US - Stati Uniti d'America 17.303
SG - Singapore 2.123
VN - Vietnam 1.413
RU - Federazione Russa 1.350
IT - Italia 1.106
CN - Cina 1.057
BR - Brasile 1.045
HK - Hong Kong 853
IE - Irlanda 687
FR - Francia 506
DE - Germania 451
SE - Svezia 293
UA - Ucraina 290
GB - Regno Unito 278
IN - India 276
BD - Bangladesh 198
CA - Canada 179
MA - Marocco 149
AR - Argentina 107
MX - Messico 105
FI - Finlandia 93
CI - Costa d'Avorio 83
ZA - Sudafrica 75
IQ - Iraq 64
NL - Olanda 60
JP - Giappone 56
PL - Polonia 53
CO - Colombia 49
PK - Pakistan 48
ES - Italia 47
AT - Austria 45
VE - Venezuela 45
TR - Turchia 44
EC - Ecuador 43
ID - Indonesia 43
PH - Filippine 38
UZ - Uzbekistan 35
RO - Romania 33
SA - Arabia Saudita 25
DZ - Algeria 24
CL - Cile 23
NP - Nepal 23
AE - Emirati Arabi Uniti 22
BE - Belgio 21
JO - Giordania 21
CH - Svizzera 18
KR - Corea 18
TH - Thailandia 18
EU - Europa 17
LT - Lituania 17
TN - Tunisia 17
AU - Australia 15
EG - Egitto 15
ET - Etiopia 15
KE - Kenya 15
PY - Paraguay 14
JM - Giamaica 13
MY - Malesia 13
AL - Albania 12
AZ - Azerbaigian 12
UY - Uruguay 11
PE - Perù 10
PT - Portogallo 10
TW - Taiwan 10
BO - Bolivia 9
HN - Honduras 9
CR - Costa Rica 8
DO - Repubblica Dominicana 8
KZ - Kazakistan 8
SN - Senegal 8
BH - Bahrain 7
TT - Trinidad e Tobago 7
IL - Israele 6
IR - Iran 6
LB - Libano 5
NI - Nicaragua 5
PA - Panama 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
BN - Brunei Darussalam 4
CY - Cipro 4
CZ - Repubblica Ceca 4
DM - Dominica 4
GR - Grecia 4
OM - Oman 4
PR - Porto Rico 4
RS - Serbia 4
AM - Armenia 3
GT - Guatemala 3
HU - Ungheria 3
KW - Kuwait 3
NG - Nigeria 3
QA - Qatar 3
SV - El Salvador 3
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
GE - Georgia 2
GH - Ghana 2
Totale 31.321
Città #
Ashburn 3.538
Singapore 1.428
San Jose 1.192
Fairfield 956
Des Moines 916
Chandler 851
Hong Kong 822
Jacksonville 806
Dallas 754
Dublin 665
Council Bluffs 530
Boardman 475
The Dalles 472
Ho Chi Minh City 435
Woodbridge 420
Wilmington 404
Seattle 396
Houston 373
New York 363
Hanoi 356
Cambridge 328
Beijing 287
Lauterbourg 265
Los Angeles 258
Lawrence 246
Princeton 245
San Mateo 209
Ann Arbor 193
Moscow 150
Pune 143
Milan 142
Santa Clara 111
San Diego 109
São Paulo 98
Ancona 95
Hefei 92
Redmond 92
Washington 92
Munich 88
Chicago 87
Abidjan 83
Da Nang 77
London 76
Columbus 71
Orem 69
Brooklyn 56
Turin 56
Buffalo 55
Helsinki 54
Montreal 54
Rome 54
Frankfurt am Main 52
Haiphong 49
Tokyo 49
San Francisco 47
Warsaw 46
Nuremberg 45
Phoenix 45
Atlanta 43
Shanghai 43
Miano 39
Turku 39
Chennai 38
Johannesburg 38
Denver 37
Rio de Janeiro 37
Mexico City 36
Stockholm 35
Tashkent 34
Amsterdam 31
Boston 31
Toronto 31
Guangzhou 30
Manchester 29
Norwalk 28
Vienna 25
Dhaka 23
Belo Horizonte 21
Naples 21
Auburn Hills 20
Caracas 20
Miami 20
Amman 19
Baghdad 19
Cape Town 19
Curitiba 19
Poplar 19
Salt Lake City 19
Paris 18
Tolentino 18
Ankara 17
Biên Hòa 17
Brussels 17
Kilburn 17
Shenzhen 17
Can Tho 16
Lahore 16
Mumbai 16
Guayaquil 15
Nanjing 15
Totale 21.582
Nome #
Italian Cardiological Guidelines (COCIS) for Competitive Sport Eligibility in athletes with heart disease: update 2024 429
Interpretation and management of premature ventricular beats in athletes: An expert opinion document of the Italian Society of Sports Cardiology (SICSPORT) 391
National workflow experience with pulsed field ablation for atrial fibrillation: learning curve, efficiency, and safety 267
Cardiac arrhythmia catheter ablation procedures guided by x-ray imaging: N-acetylcysteine protection against radiation-induced cellular damage (CARAPACE study): study design 216
Recent advances in three-dimensional electroanatomical mapping guidance for the ablation of complex atrial and ventricular arrhythmias 200
Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC Task Force Criteria 200
Long-Term Arrhythmic Risk Assessment in Biopsy-Proven Myocarditis 199
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on a Tertiary-Level Electrophysiology Laboratory in Italy 183
Characteristics of Patients With Arrhythmogenic Left Ventricular Cardiomyopathy: Combining Genetic and Histopathologic Findings 176
Characteristics and Prognosis of a Contemporary Cohort with Myocardial Infarction with Non-Obstructed Coronary Arteries (MINOCA) Presenting Different Patterns of Late Gadolinium Enhancements in Cardiac Magnetic Resonance Imaging 169
Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Arrhythmia-free survival after endo-epicardial substrate based mapping and ablationablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy arrhythmia-free survival after endo-epicardial substrate based mapping and ablation 169
Procedural sedation for direct current cardioversion: a feasibility study between two management strategies in the emergency department 166
Acute outcome after a single cryoballoon ablation: Comparison between Arctic Front Advance and Arctic Front Advance PRO 161
Pulsed field vs very high-power short-duration radiofrequency ablation for atrial fibrillation: Results of a multicenter, real-world experience 160
A randomized comparison of alternative techniques to achieve coronary sinus cannulation during biventricular implantation procedures 159
Ablation Index Predicts Successful Ablation of Focal Atrial Tachycardia: Results of a Multicenter Study 156
Echocardiographic size of conductance vessels in athletes and sedentary people 156
Ablation Index as a predictor of long-term efficacy in premature ventricular complex ablation: A regional target value analysis 155
Arrhythmic Mitral Valve Prolapse and Sports Activity: Pathophysiology, Risk Stratification, and Sports Eligibility Assessment 151
Ablation for longstanding permanent atrial fibrillation: Results from a randomized study comparing three different strategies 151
Scar Homogenization Versus Limited-Substrate Ablation in Patients With Nonischemic Cardiomyopathy and Ventricular Tachycardia 150
Worldwide Survey of COVID-19-Associated Arrhythmias 149
Ablation of perimitral flutter following catheter ablation of atrial fibrillation: Impact on outcomes from a randomized study (PROPOSE) 147
Rate and impact on patient outcome and healthcare utilization of complications requiring surgical revision: Subcutaneous versus transvenous implantable defibrillator therapy 143
Myocardial Infarction Without Obstructive Coronary Artery Disease (MINOCA): A Practical Guide for Clinicians 142
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial 141
Long-Term Outcomes of Near-Zero Radiation Ablation of Paroxysmal Supraventricular Tachycardia: A Comparison With Fluoroscopy-Guided Approach 141
Novel risk calculator performance in athletes with arrhythmogenic right ventricular cardiomyopathy 139
Prior myocarditis and ventricular arrhythmias: the importance of scar pattern 138
Implantable defibrillator-detected heart failure status predicts ventricular tachyarrhythmias 137
Diagnostic Yield of Electroanatomic Voltage Mapping in Guiding Endomyocardial Biopsies 137
Additional diagnostic value of cardiac magnetic resonance feature tracking in patients with biopsy-proven arrhythmogenic cardiomyopathy 137
Recurrence of atrial fibrillation post-ablation: which is the most effective approach for detection? 136
Safety and outcomes of cryoablation for ventricular tachyarrhythmias: Results from a multicenter experience 136
Sports Activity and Arrhythmic Risk in Cardiomyopathies and Channelopathies: A Critical Review of European Guidelines on Sports Cardiology in Patients with Cardiovascular Diseases 135
An ablation index operator-independent approach to improve efficacy in atrial fibrillation ablation at 24-month follow-up: a single center experience 134
Acute shock efficacy of the subcutaneous implantable cardioverter-defibrillator according to the implantation technique 134
Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study 134
Pathophysiology of Typical Atrial Flutter 132
Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience 132
Prevalence and clinical significance of collateral findings detected by chest computed tomography in patients undergoing atrial fibrillation ablation 132
A randomized evaluation of different approaches to coronary sinus venography during biventricular pacemaker implants 132
C-reactive protein is associated with recurrent episodes of ventricular tachycardia and ventricular fibrillation in ischemic patients with implantable cardioverter defibrillator 132
Subclinical progression of systemic sclerosis-related cardiomyopathy 130
Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy the VISTA Randomized Multicenter Trial 130
Prospective use of ablation index for the ablation of right ventricle outflow tract premature ventricular contractions: a proof of concept study 130
A retrospective analysis of clinical and genetic data on a large cohort of Italian DM1 patients 128
Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience 127
Acute Kidney Injury Resulting From Hemoglobinuria After Pulsed-Field Ablation in Atrial Fibrillation: Is it Preventable? 126
"Near-zero" fluoroscopic exposure in supraventricular arrhythmia ablation using the EnSite NavX" mapping system: Personal experience and review of the literature 126
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring With Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 125
Ablation of ventricular arrhythmias in right ventricular dysplasia: arrhythmias free survival after endo-epicardial substrate based mapping and ablation 125
Role of Intracardiac echocardiography in Atrial Fibrillation Ablation 125
Safety and Efficacy of Stereotactic Arrhythmia Radioablation for the Treatment of Ventricular Tachycardia: A Systematic Review 124
High-power short-duration catheter ablation of atrial fibrillation: is it really a new era? Comparison between new and old radiofrequency contact force–sensing catheters 124
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study 123
Characteristics and Clinical Value of Electroanatomic Voltage Mapping in Cardiac Amyloidosis 123
Rationale and design of the NO-PARTY trial: Near-zero fluoroscopic exposure during catheter ablation of supraventricular arrhythmias in young patients 123
Atrial Flutters in Adults with Congenital Heart Disease 120
Posterior wall ablation for persistent atrial fibrillation: Very-high-power short-duration versus standard-power radiofrequency ablation 120
"NEAR ZERO" FLUOROSCOPIC EXPOSURE IN SUPRAVENTRICULAR ARRHYTHMIA ABLATION USING THE ENSITE NAVXTM MAPPING SYSTEM 120
Decongestive treatment adjustments in heart failure patients remotely monitored with a multiparametric implantable defibrillators algorithm 120
Microelectrode voltage mapping for substrate assessment in catheter ablation of ventricular tachycardia: A dual-center experience 119
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 119
Ventricular arrhythmias induced by long-term use of ephedrine in two competitive athletes 119
Derivation and Validation of a Clinical Score for Predicting Postoperative Atrial Fibrillation in Noncardiac Elective Surgery (the HART Score) 118
Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: The impact of periprocedural therapeutic international normalized ratio 118
Clinical impact of catheter ablation in patients with asymptomatic atrial fibrillation: The IRON-AF (Italian Registry on NavX Atrial Fibrillation Ablation Procedures) study 118
Rhythm-symptom correlation in patients on continuous monitoring after catheter ablation of atrial fibrillation 118
Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis 117
Near zerO fluoroscopic exPosure during catheter ablAtion of supRavenTricular arrhYthmias: The NO-PARTY multicentre randomized trial 117
Clinical and Molecular Data Define a Diagnosis of Arrhythmogenic Cardiomyopathy in a Carrier of a Brugada-Syndrome-Associated PKP2 Mutation 117
Concealed cardiomyopathies in competitive athletes with ventricular arrhythmias and an apparently normal heart: Role of cardiac electroanatomical mapping and biopsy 117
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry 117
Electrocardiogram for the Diagnosis of Acute Myocardial Infarction in Patients with Right Ventricular Paced Rhythm: Old but Gold 116
Efficacy of Catheter Ablation for Atrial Arrhythmias in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy-A Multicenter Study 116
Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantation 116
Pulmonary-vein isolation for atrial fibrillation in patients with heart failure 116
Catheter ablation of atrial fibrillation: Randomized controlled trials and registries, a look back and the view forward 116
Combined use of cryoballoon and focal open-irrigation radiofrequency ablation for treatment of persistent atrial fibrillation: Results from a pilot study 116
Characteristics of patients with recurrent acute myocardial infarction after MINOCA 115
Compassionate drug use for patients with transthyretin amyloid cardiomyopathy 115
Different Phases of Disease in Lymphocytic Myocarditis: Clinical and Electrophysiological Characteristics 114
Endomyocardial biopsy: The forgotten piece in the arrhythmogenic cardiomyopathy puzzle 114
X-ray exposure in cardiac electrophysiology: A retrospective analysis in 8150 patients over 7 years of activity in a modern, large-volume laboratory 113
Use of Ablation Index-Guided Ablation Results in High Rates of Durable Pulmonary Vein Isolation and Freedom From Arrhythmia in Persistent Atrial Fibrillation Patients 112
S-ICD is effective in preventing sudden death in arrhythmogenic cardiomyopathy athletes during exercise 112
CMR for Identifying the Substrate of Ventricular Arrhythmia in Patients With Normal Echocardiography 112
Right ventricular substrate mapping using the Ensite Navx system: Accuracy of high-density voltage map obtained by automatic point acquisition during geometry reconstruction 111
3D-electroanatomic mapping-guided endomyocardial biopsy findings in patients with Brugada syndrome 111
Prevalence and outcome of silent hypoxemia in COVID-19 110
Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: A systematic review and meta-analysis 109
Widespread electroanatomic alterations of right cardiac chambers in patients with myotonic dystrophy type 1 109
Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: Results from a prospective risk stratification study 109
Cardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutations 109
Electroanatomical mapping systems and intracardiac echo integration for guided endomyocardial biopsy 109
Angina in 2022: Current Perspectives 108
Idiopathic Premature Ventricular Contraction Catheter Ablation, Sedentary Population vs. Athlete’s Populations: Outcomes and Resumption of Sports Activity 107
An atlas of radioscopic catheter placement for the electrophysiologist 107
Left atrial appendage: An underrecognized trigger site of atrial fibrillation 107
Totale 13.876
Categoria #
all - tutte 168.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.081


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.713 0 457 32 55 139 83 100 120 143 106 160 318
2022/20233.454 282 194 214 281 139 1.114 12 177 742 37 154 108
2023/20242.253 341 52 157 229 361 579 53 96 40 103 25 217
2024/20254.619 195 502 223 70 166 155 528 218 1.047 312 527 676
2025/202614.045 904 764 721 955 1.414 868 2.858 1.443 1.331 1.380 732 675
2026/20271.434 648 786 0 0 0 0 0 0 0 0 0 0
Totale 32.129